Recon: Judge blocks CDC’s overhaul of childhood vaccines; FDA rejects Aldeyra’s eye disorder drug

• NIH grant awards are again lagging far behind historical averages, analysis shows (STAT)
• Federal judge stalls health secretary RFK Jr.’s overhaul of vaccine policy (STAT)
• Pediatricians win Round 1 in vaccine fight, but damage has been done (Reuters)
• Asthma patients suffered as GSK pursued ‘egregious’ price hikes, senator says (STAT)
• White House digs in on ‘most-favored nation’ drug pricing despite Congress’ cool reception (STAT)
• US FDA declines to approve Aldeyra's eye disorder drug, shares slump (Reuters)

• Exclusive: China mRNA therapy startup Innorna to test gout treatment in US (Endpoints)
• MDR/IVDR Changes And A Question of Balance: EU’s Várhelyi On Device Safety And Innovation (MedTech Insight)
• Denmark Aims To Streamline First-In-Human Trials For Advanced Therapies (Pink Sheet)
• Valneva Asked To Strengthen Ixchiq Label After EMA’s Meningitis Signal Review (Pink Sheet)

• Roche, Nvidia will build pharma's largest 'AI factory,' eclipsing Lilly's supercomputer (Endpoints)
• Bicycle to cut 30% of staff after cancer drug's regulatory setback (Endpoints)
• Rhythm’s Imcivree fails Phase 3 for rare form of obesity as PDUFA date nears for larger indication (Endpoints)
• J&J pulls out of JLABS New York location as it shrinks incubator footprint (Endpoints)
• New renal disease biotech R1 Therapeutics nabs $77.5M for Phase 2b (Endpoints)
• BioMarin halts Phase 2 Voxzogo dosing in certain patients over safety concern (Endpoints)
• Lilly Gets Lone Sell From HSBC Ahead of Deeper Weight Loss Drug Price Cuts (Bloomberg)
• Alibaba AI Takes Aim at Silent Liver Epidemic (Bloomberg)

• Stryker attack raises concerns about role of device management tool (MedTech Dive)
• Alcon abandons effort to purchase LENSAR after FTC scrutiny (MedTech Dive)
• Vicarious Surgical applies for Nasdaq listing (MedTech Dive)
• AI Precision Testing Will Be Standard Of Care Within 5 Years, Says Waiv CEO After $33M Raise (MedTech Insight)
• BCI Maker Paradromics Builds Academic Network To Advance Brain-Computer Interface Research (MedTech Insight)

• Snack Brands Jockey to Invent the Next Hit Chip (Bloomberg)
• JBS workers go on strike at one of largest beef plants in the US (Food Dive)

• For decades, they’ve set the record straight in biology. Next up: science’s reproducibility crisis (STAT)
• Viridian’s Severe Thyroid Eye Disease Drug Veligrotug Among Latest EU Filings (Pink Sheet)
• The greatest threat to federally qualified health centers may not be federal funding cuts (STAT)